Plasmonic gold nanostars for synergistic photoimmunotherapy to treat cancer.

Journal Article (Journal Article;Review)

Cancer is the second leading cause of death and there is an urgent need to improve cancer management. We have developed an innovative cancer therapy named Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) by combining gold nanostars (GNS)-mediated photothermal ablation with checkpoint inhibitor immunotherapy. Our previous studies have demonstrated that SYMPHONY photoimmunotherapy not only treats the primary tumor but also dramatically amplifies anticancer immune responses in synergy with checkpoint blockade immunotherapy to treat remote and unresectable cancer metastasis. The SYMPHONY treatment also induces a 'cancer vaccine' effect leading to immunologic memory and prevents cancer recurrence in murine animal models. This manuscript provides an overview of our research activities on the SYMPHONY therapy with plasmonic GNS for cancer treatment.

Full Text

Duke Authors

Cited Authors

  • Liu, Y; Chorniak, E; Odion, R; Etienne, W; Nair, SK; Maccarini, P; Palmer, GM; Inman, BA; Vo-Dinh, T

Published Date

  • September 2021

Published In

Volume / Issue

  • 10 / 12

Start / End Page

  • 3295 - 3302

PubMed ID

  • 36405500

Pubmed Central ID

  • PMC9646244

International Standard Serial Number (ISSN)

  • 2192-8606

Digital Object Identifier (DOI)

  • 10.1515/nanoph-2021-0237


  • eng

Conference Location

  • Germany